Quantum Biopharma (QNTM) Operating Leases (2019 - 2022)

Quantum Biopharma (QNTM) has 4 years of Operating Leases data on file, last reported at $38004.0 in Q4 2022.

• For the quarter ending Q4 2022, Operating Leases fell 71.0% year-over-year to $38004.0; the trailing twelve-month figure through Dec 2022 stood at $38004.0 (down 71.0% YoY), and the FY2022 full-year result was $38004.0, down 71.0% from the prior year.
• Operating Leases declined to $38004.0 in Q4 2022, from $131045.0 in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $153672.9 in Q4 2019 to a low of $38004.0 in Q4 2022.
• A 4-year average of $112171.0 and a median of $128503.5 in 2020 frame the typical range for Operating Leases.
• Across the five-year window, Operating Leases grew 4.04% in 2021 and plunged 71.0% in 2022, its largest moves.
• Tracing QNTM's Operating Leases over 4 years: stood at $153672.9 in 2019, then fell by 18.03% to $125962.0 in 2020, then rose by 4.04% to $131045.0 in 2021, then sank by 71.0% to $38004.0 in 2022.
• Business Quant data shows QNTM's Operating Leases at $38004.0 in Q4 2022, $131045.0 in Q4 2021, and $125962.0 in Q4 2020.